Rhythm Pharmaceuticals
RYTM
RYTM
176 hedge funds and large institutions have $3.55B invested in Rhythm Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 30 funds opening new positions, 62 increasing their positions, 54 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
15% more repeat investments, than reductions
Existing positions increased: 62 | Existing positions reduced: 54
7% more funds holding
Funds holding: 165 → 176 (+11)
2.92% less ownership
Funds ownership: 113.66% → 110.75% (-2.9%)
Holders
176
Holding in Top 10
10
Calls
$46M
Puts
$4.75M
Top Buyers
| 1 | +$33.4M | |
| 2 | +$32.2M | |
| 3 | +$15.7M | |
| 4 |
SI
Sofinnova Investments
Menlo Park,
California
|
+$14.5M |
| 5 |
Alkeon Capital Management
New York
|
+$8.79M |
Top Sellers
| 1 | -$73.8M | |
| 2 | -$30.1M | |
| 3 | -$24.8M | |
| 4 |
Canada Pension Plan Investment Board
Toronto Ontario,
Ontario, Canada
|
-$18.3M |
| 5 |
Nisa Investment Advisors
St. Louis,
Missouri
|
-$16.1M |